InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that over 20 studies of its novel BTK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback